Next Generation in Protein Characterization

Aggregation

Quantitation

Stability

Structure

Similarity

"RedShiftBio provides a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality."

product-email-version-rsb

AQS3pro Microfluidic Modulation Spectrometer

AQS3_TM_pro-75

The Next Generation in Protein Characterization

The AQS3pro brings protein secondary structure measurement into every stage of the biopharmaceutical pipeline. Measuring in conditions that were previously not possible with traditional methods, MMS provides repeatable, high sensitivity, automated measurement across a wide concentration range, in any formulation.

See change in your protein, in your workflow, and in your efficiency.

Higher Order Structure (HOS) 2020, Apr 20-22, Gaithersburg, MD - CANCELED

13th Annual Proteins & Antibodies Congress, Apr 27-29, London, UK - POSTPONED

PEGS, May 4-8, Boston, MA

ASMS, May 31 - June 4, Houston, TX

Well Characterized Biologics and Biological Assays, Oct 27-29, Hyattsville, MD

PEGS EU, Nov 2020, Lisbon, Portugal

RedShiftBio®

RedShiftBio® is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.

Read More

Awards

TAS-footer
prism-logo-footer

Contact Us

RedShift BioAnalytics Inc.

131 Middlesex Turnpike
Burlington, MA 01803

T: 781.345.7300
F: 781-345-7301
E: info@redshiftbio.com

RedShift™, RedShiftBio®,  See Change®, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.